Toronto, Ontario--(Newsfile Corp. - February 18, 2025) - Canadian Gold Corp. (TSXV: CGC) ("Canadian Gold" or the "Company"), is pleased to announce ongoing drill results from its Phase 4 drill program
Canopy Growth recently reported improved Q3-2025 financial results. They expect continued growth across operating segments. The company's stock price is down 46% over the last twelve months.
NEW YORK CITY, NY / ACCESS Newswire / February 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Canopy Growth Corporation ("Canopy" or the "Company") (NASDAQ:CGC). Such inves
The growth of the cannabis industry is set to have a profound impact on marijuana stocks in 2025. With an increasing number of states and countries legalizing cannabis, the market is expanding rapidly
Together with Blue Sourberry and Altitude Lemon Lime, Deep Space Propulsion Continues to Pioneer the High-Potency Cannabis Beverage Category with its Expanded Portfolio of Innovative Flavours SMITHS F
Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
19.4 gpt Gold over 4.5 M Within 7.4 gpt Gold over 13.5 M Western Flank Continues to Grow 8.0 gpt Gold over 5.2 M Toronto, Ontario--(Newsfile Corp. - February 10, 2025) - Canadian Gold Corp. (TSXV: CGC
Canopy Growth Corporation (NASDAQ:CGC ) Q3 2025 Earnings Conference Call February 7, 2025 10:00 AM ET Company Participants Tyler Burns - Director, IR Luc Mongeau - CEO Judy Hong - CFO Conference Call
On Friday, Canopy Growth Corporation CGC reported third-quarter 2025 sales of CA$74.76 million, down from CA$78.51 million a year ago, beating the consensus of CA$69.11 million.
Canopy Growth Corporation (TSX:WEED, NYSE:CGC) shares plummeted after the Ontario-headquartered cannabis producer reported a greater than forecast loss for the fiscal third quarter.   For the Decembe
Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.76 per share versus the Zacks Consensus Estimate of a loss of $0.48. This compares to loss of $1.79 per share a year ago.
Canopy's stock reversed on earnings after seeing a rally sparked by the possibility of marijuana reform in the U.S.
Strong holiday sales drove Storz & Bickel net revenue growth of 19% year-over-year   Record quarter for Canada medical cannabis with net revenue increasing 16%; international markets cannabis net re
Canopy Growth Corporation is likely to report weak financials when reporting FQ3 results on February 7. The company struggles with low gross margins of 35% and continues to burn cash, while a peer's r
Cannabis stocks tend to move on speculation around potential federal reforms around pot.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE